壶腹部肿瘤病灶基底≥20 mm:内镜黏膜下剥离术与内镜乳头切除术的回顾性对比研究
这项单中心回顾性研究比较了病灶基底≥20 mm的壶腹部肿瘤行内镜黏膜下剥离术(ESD)与内镜乳头切除术(EP)的效果。尽管ESD组肿瘤中位尺寸更大(35 vs 23 mm,P<.001),其整块切除率(100% vs 71.7%,P=.007)和R0切除率(89.5% vs 30.2%,P<.001)均显著更高。随访≥1年时,ESD组局部控制更优,无残留病变(0% vs 42.9%,P<.001)。
要点
- 对基底≥20 mm的壶腹部肿瘤,ESD整块切除率和R0切除率显著高于EP。
- ESD组随访≥1年无残留病变比例显著优于EP,局部控制更持久。
- 两组总体不良事件发生率相当,但ESD操作时间更长、技术复杂度更高。
核心结论
- 对于基底≥20 mm的壶腹部肿瘤,ESD相比EP可获得更优的切除质量和持久的局部控制。
- ESD技术复杂且操作风险需谨慎管理,但仍可作为高效替代方案。
研究设计与样本
- 单中心回顾性比较研究,纳入2004年3月至2026年4月连续接受ESD或EP的基底≥20 mm壶腹部肿瘤患者。
- 2020年12月后,对机械上不适合整块圈套切除的病变优先选择ESD。
主要发现
- ESD组肿瘤中位尺寸为35 mm,EP组为23 mm(P<.001)。
- ESD组整块切除率为100%,EP组为71.7%(P=.007)。
- ESD组R0切除率为89.5%,EP组为30.2%(P<.001)。
- 随访≥1年时(ESD组17例,EP组49例),ESD组残留病变0%,EP组42.9%(P<.001);ESD组需追加内镜治疗0%,EP组44.9%(P<.001)。
- ESD组最终临床缓解率为100%,EP组为87.8%;总体不良事件发生率分别为36.8%和22.6%(P=.241)。
临床怎么用
- 对于基底≥20 mm、符合纳入标准的壶腹部腺瘤或黏膜癌,ESD可作为优先考虑以追求整块和R0切除。
- 需充分评估ESD的技术难度和操作时间,并做好不良事件的管理准备。
局限性
- ESD组和EP组肿瘤大小存在显著差异,可能影响结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Optimal endoscopic management of ampullary tumors with a large base (≥20 mm) remains unclear. We compared the outcomes of endoscopic submucosal dissection (ESD) versus endoscopic papillectomy (EP). METHODS: This retrospective study included consecutive patients undergoing ESD or EP for ≥20-mm base ampullary tumors (March 2004-April 2026). Inclusion required adenoma or mucosal carcinoma and intraductal extension ≤10 mm. After December 2020, ESD was prioritized for lesions mechanically unsuitable for en bloc snaring. Primary outcomes were en bloc and complete (margin-negative) resection (R0) rates; long-term local control and adverse events (AEs) were also evaluated. RESULTS: Seventy-two patients underwent resection (ESD, n = 19; EP, n = 53). Despite larger median tumor sizes (35 vs 23 mm; P < .001), ESD achieved significantly higher en bloc (100% vs 71.7%; P = .007) and R0 (89.5% vs 30.2%; P < .001) resection rates. With ≥1-year follow-up (ESD, n = 17; EP, n = 49), ESD demonstrated superior local control, with 0% residual disease (vs 42.9%; P < .001), 0% recurrence (vs 12.2%; P = .326), and 0% requiring additional endoscopic treatment (vs 44.9%; P < .001). Final clinical remission was 100% versus 87.8%. Despite longer ESD procedure times, overall AE rates were comparable (36.8% vs 22.6%; P = .241). CONCLUSIONS: For ≥20-mm base ampullary tumors, ESD yields superior resection quality and durable local control compared with EP. Although its technical complexity and procedural risks warrant careful management, ESD serves as a highly effective alternative.
引用
- Fukuzawa K, Hirose T, Takada Y, et al. Endoscopic submucosal dissection versus endoscopic papillectomy for ampullary tumors with a lesion base ≥20 mm: a single-center retrospective comparative study (with videos). Gastrointest Endosc. 2026. PMID: 42250774. doi:10.1016/j.gie.2026.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。